Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 484% % 2.2%
Debt-to-equity -1118% % -131%
Return On Equity 580% % 97%
Return On Assets -57% % -0.71%
Operating Margin 528% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12,304,352 shares 1%
Common Stock, Shares, Outstanding 12,304,352 shares 1.4%
Entity Public Float $136,400,000 USD 198%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 12,240,542 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 12,240,542 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $26,385,000 USD -43%
General and Administrative Expense $17,117,000 USD 2%
Operating Income (Loss) $43,502,000 USD 44%
Nonoperating Income (Expense) $1,425,000 USD -92%
Income Tax Expense (Benefit) $21,000 USD -95%
Net Income (Loss) Attributable to Parent $42,098,000 USD 31%
Earnings Per Share, Basic -5 USD/shares 93%
Earnings Per Share, Diluted 0 USD/shares 59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $49,039,000 USD -45%
Other Assets, Current $24,000 USD -90%
Assets, Current $50,810,000 USD -46%
Property, Plant and Equipment, Net $1,069,000 USD -28%
Operating Lease, Right-of-Use Asset $5,258,000 USD -10%
Other Assets, Noncurrent $0 USD -100%
Assets $57,784,000 USD -45%
Accounts Payable, Current $973,000 USD -23%
Employee-related Liabilities, Current $1,922,000 USD -45%
Accrued Liabilities, Current $3,905,000 USD -56%
Liabilities, Current $11,110,000 USD -23%
Operating Lease, Liability, Noncurrent $5,121,000 USD -12%
Other Liabilities, Noncurrent $55,000,000 USD 0%
Liabilities $76,232,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $262,723,000 USD -19%
Stockholders' Equity Attributable to Parent $18,448,000 USD -201%
Liabilities and Equity $57,784,000 USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,482,000 USD 14%
Net Cash Provided by (Used in) Financing Activities $99,346,000 USD 662207%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 12,304,352 shares 1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $49,686,000 USD -45%
Deferred Tax Assets, Valuation Allowance $106,876,000 USD 94%
Deferred Tax Assets, Gross $108,634,000 USD 90%
Operating Lease, Liability $5,792,000 USD -15%
Depreciation $483,000 USD 22%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $42,097,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid $7,326,000 USD -17%
Property, Plant and Equipment, Gross $2,823,000 USD 0.07%
Operating Lease, Liability, Current $671,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,092,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $265,000 USD -62%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,534,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,124,000 USD 2.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,158,000 USD 3%
Additional Paid in Capital $244,273,000 USD 2.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $5,037,000 USD 38%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares